Cell cycle inhibition in patients with mantle cell lymphoma (#492)
Laufzeit: 01.01.2013 - 31.12.2018
imported
Kurzfassung
Phase II study of a CDK4/6 inhibitor for patients with relapsed or refractory mantle cell lymphoma
Laufzeit: 01.01.2013 - 31.12.2018
Phase II study of a CDK4/6 inhibitor for patients with relapsed or refractory mantle cell lymphoma